Combining EGF receptor inhibitors with chemotherapy or chemoradiotherapy in patients with non-small-cell lung cancer

Author： Bastos Bruno R   Lilenbaum Rogerio C  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.8, Iss.1, 2011-01, pp. : 9-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Value of Synaptophysin and Chromogranin A Expression in Patients Receiving Palliative Chemotherapy for Advanced Non-Small-Cell Lung Cancer

By  

Respiration, Vol. 85, Iss. 4, 2012-04 ,pp. : 289-296

Karger

Access to resources Recommend Favorite

New Drugs in the Palliative Chemotherapy of Advanced Non-Small-Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 5, 2001-10 ,pp. : 416-421

Karger

Access to resources Recommend Favorite

Palliative Chemotherapy in Advanced Non-Small-Cell Lung Cancer: Goals and Reality

By  

Oncology Research and Treatment, Vol. 22, Iss. 1, 1999-03 ,pp. : 63-64

Karger

Access to resources Recommend Favorite

Management of acquired resistance to epidermal growth factor receptor kinase inhibitors in patients with advanced non‐small cell lung cancer

By  

CANCER, Vol. 120, Iss. 15, 2014-08 ,pp. : 2289-2298

John Wiley & Sons Inc

Access to resources Recommend Favorite

Chemotherapy in Non-Small Cell Lung Cancer Patients Receiving Oxygen Therapy

By  

Oncology Research and Treatment, Vol. 39, Iss. 10, 2016-09 ,pp. : 587-590

Karger

Access to resources Recommend Favorite